- Home
- PDX vs MDXG Comparison
PDX vs MDXG Comparison
Compare PDX & MDXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PDX
- MDXG
- Stock Information
- Founded
- PDX 2019
- MDXG 2006
- Country
- PDX NY
- MDXG United States
- Employees
- PDX N/A
- MDXG N/A
- Industry
- PDX Finance/Investors Services
- MDXG Biotechnology: Pharmaceutical Preparations
- Sector
- PDX Finance
- MDXG Health Care
- Exchange
- PDX Nasdaq
- MDXG Nasdaq
- Market Cap
- PDX 1.1B
- MDXG 1.2B
- IPO Year
- PDX N/A
- MDXG N/A
- Fundamental
- Price
- PDX $24.41
- MDXG $7.60
- Analyst Decision
- PDX
- MDXG Strong Buy
- Analyst Count
- PDX 0
- MDXG 3
- Target Price
- PDX N/A
- MDXG $12.00
- AVG Volume (30 Days)
- PDX N/A
- MDXG 535.9K
- Earning Date
- PDX 01-01-0001
- MDXG 04-29-2025
- Dividend Yield
- PDX 4.95%
- MDXG N/A
- EPS Growth
- PDX N/A
- MDXG N/A
- EPS
- PDX N/A
- MDXG 0.28
- Revenue
- PDX N/A
- MDXG $348,879,000.00
- Revenue This Year
- PDX N/A
- MDXG $10.09
- Revenue Next Year
- PDX N/A
- MDXG $11.77
- P/E Ratio
- PDX N/A
- MDXG $26.93
- Revenue Growth
- PDX N/A
- MDXG 8.52
- 52 Week Low
- PDX $13.52
- MDXG $5.47
- 52 Week High
- PDX $21.05
- MDXG $10.14
- Technical
- Relative Strength Index (RSI)
- PDX 53.39
- MDXG 38.98
- Support Level
- PDX $23.70
- MDXG $7.84
- Resistance Level
- PDX $24.52
- MDXG $8.12
- Average True Range (ATR)
- PDX 0.50
- MDXG 0.24
- MACD
- PDX 0.16
- MDXG -0.02
- Stochastic Oscillator
- PDX 100.00
- MDXG 24.05
About PDX PIMCO Dynamic Income Strategy Fund of Beneficial Interest
PIMCO Dynamic Income Strategy Fund is a non-diversified, limited term, closed-end management investment company registered under the Investment Company. The fund's primary investment objective is to seek current income as a primary objective and capital appreciation as a secondary objective.
About MDXG MiMedx Group Inc
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are primarily targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.